Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

America's pharmaceutical founding fathers Meanwhile ... With its hepatitis C drugs, Gilead faced huge amounts of controversy over the initial costs of its therapies, although these were reduced ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Nvidia is constructing one of the largest server farms in Israel, close to the Elyakim Interchange near Yokne’am in the north ...

The liver cirrhosis treatment market is poised for significant growth, driven by the rising global prevalence of liver diseases, particularly NAFLD, fueled by lifestyle factors like obesity, alcohol ...

Nvidia is constructing one of the largest server farms in Israel, close to the Elyakim Interchange near Yokne’am in the north ...

Pharma And Healthcare Social Media Market Size, Growth Drivers And Global Forecast 2032 At A Thriving CAGR Of 7.65% The Global Pharma and Healthcare Social Media market is significantly influenced by ...